Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
159 Leser
Artikel bewerten:
(0)

CompuGroup Medical's CGM LabDAQ Laboratory Information System Receives Quest Diagnostics Quality Solutions Certification

OWINGS MILLS, Md., Jan. 21, 2014 /PRNewswire/ --CompuGroup Medical US announced today that CGM LabDAQ LIS has been certified as a Gold Quality Solution by Quest Diagnostics under Quest's Health IT Quality Solutions' Program (the "Program"). Quest Diagnostics is the world's leading provider of diagnostic information services.

As a certified Health IT Quality Solution, CompuGroup Medical's CGM LabDAQ has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions.

Quest Diagnostics created the Health IT Quality Solutions Program to collaborate with providers of electronic health record (EHR) and other clinical technologies such as CGM LabDAQ to achieve optimized levels of clinical and operational quality for the benefit of physician practices, hospitals, and integrated delivery networks. The Program is designed to maximize data quality, as well as data and business process interoperability between Quest Diagnostics and select clinical technology solutions that meet Quest's high standards.

"We believe that this certification validates our seamless integration with Quest Diagnostics and solidifies our 15 year progressive and growing partnership," said Jim Kasoff, President, CompuGroup Medical, Laboratory Division.

To be eligible for the Program, a clinical technology solution must have an approved and commercially viable interface to Quest Diagnostics web service's Data Exchange Service, which processes both lab orders and results. It can then qualify for one of three certification tiers -- Silver, Gold, or Platinum -- by meeting an increasingly stringent and comprehensive set of criteria related to laboratory order and result functionality, implementation processes, and other mutually-beneficial business activity.

"Certified vendors have clearly demonstrated their commitment to helping healthcare providers use technology at the highest levels of quality and process excellence in order to meet a growing set of challenges relating to information technology, regulatory requirements, and industry demands," said Keith C. Drake, Ph.D., Quality Solutions Program Executive, Quest Diagnostics. "The focus of CompuGroup Medical on quality and lab interoperability validates their leadership in the marketplace." For more information on Quest Diagnostics' Health IT Quality Solutions Program, visit QuestDiagnostics.com/QualitySolutions.

About CompuGroup Medical US

CompuGroup Medical US is the US division of CompuGroup Medical AG, -- one of the leading eHealth companies in the world. CompuGroup Medical US works to synchronize the systems of the healthcare industry with the mission of patient care, enabling providers to achieve the best possible outcomes for their patients. CompuGroup Medical US creates healthcare IT solutions to support the clinical and practice management activities that take place in physician practices, community health centers and hospitals. These solutions include Meaningful Use certified electronic health records (EHRs) that are proven to contribute to safer, higher-quality and more efficient healthcare. We also provide practice management (PM) software and productivity tools, EDI/reimbursement, lab information systems and more. For more information about CompuGroup Medical US, visit www.cgm.com/us.

About CompuGroup Medical AG

CompuGroup Medical AG is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 400,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 43 countries worldwide, CompuGroup Medical is the eHealth company with among the highest coverage among eHealth service providers. Approximately 4,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

LabDAQ is a registered trademark of CompuGroup Medical, Inc. CGM is a registered trademark of CompuGroup Medical AG.

(Logo: http://photos.prnewswire.com/prnh/20130716/NE48278LOGO)

Contact for media representatives:

CompuGroup Medical US
Kristin Brillantes
Marketing Manager, Laboratory Division
Kristin.brillantes@cgm.com
P: 800.359.0911 x1152
F: 410.517.0331

SOURCE CompuGroup Medical

© 2014 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.